Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes (Q41621738)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes |
scientific article |
Statements
1 reference
Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes (English)
1 reference
1 reference
Kenneth W Mahaffey
1 reference
Vlado Perkovic
1 reference
Dick de Zeeuw
1 reference
Greg Fulcher
1 reference
Kirk Ways
1 reference
Mehul Desai
1 reference
Wayne Shaw
1 reference
George Capuano
1 reference
Maria Alba
1 reference
Joel Jiang
1 reference
Frank Vercruysse
1 reference
Gary Meininger
1 reference
David Matthews
1 reference
CANVAS Trial Collaborative Group
1 reference
2 December 2014
1 reference
1 reference
Identifiers
1 reference